Skip to content

Septerna, Inc. SEPN Current ratio

Current ratio at other companies

Amgen logo
AmgenAMGN
1.3×+0.1×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
+0.6×
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
27.1×-3.9×
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-0.3×
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
0.9×0.0×
Precigen logo
PrecigenPGEN
4.8×+1.3×

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.65B+319%
Enterprise value$1.6B+1,325%
P/S22.8×-379×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s current ratio?
Septerna, Inc. (SEPN) reported current ratio of 4.7× in Q1 2026.
How has Septerna, Inc.'s current ratio changed year-over-year?
Septerna, Inc.'s current ratio decreased by 85.4% year-over-year, from 32.2× to 4.7×.
What is the long-term trend for Septerna, Inc.'s current ratio?
Over 2 years (2023 to 2025), Septerna, Inc.'s current ratio has grown at a -46.1% compound annual growth rate (CAGR), from 16.3× to 4.7×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.